TC BioPharm (Holdings) PLC (TCBP)
1.13
-0.01
(-0.88%)
USD |
NASDAQ |
May 17, 16:00
1.13
0.00 (0.00%)
After-Hours: 20:00
TC BioPharm Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2021 | -0.1257M |
| Date | Value |
|---|---|
| September 30, 2020 | -0.1964M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.1964M
Minimum
Sep 2020
-0.1257M
Maximum
Sep 2021
-0.161M
Average
-0.161M
Median
Cash from Investing (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | -0.358M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana PLC | 0.0038M |
| Autolus Therapeutics PLC | -1.477M |
| Mereo BioPharma Group PLC | -0.70M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | -13.42M |
| Free Cash Flow Yield | -3.84K% |